臨牀透析 Vol.21 No.1(8-2-1)


特集名 糖尿病と透析療法
題名 合併症対策 (2) 糖尿病性壊疽 1. 閉塞性動脈硬化症や糖尿病性血管障害に対する末梢血幹細胞治療
発刊年月 2005年 01月
著者 堀江 卓 札幌北楡病院外科
著者 川村 明夫 札幌北楡病院外科
著者 津田 一郎 札幌北楡病院外科
【 要旨 】 当院では閉塞性動脈硬化症(ASO) や糖尿病性血管障害を伴った血液透析患者を中心に,末梢血幹細胞 (PBSC) による血管再生治療を行ってきた.65例に行い,40例は救肢された.また,血液透析中で糖尿病性壊疽の患者は65例中16例で,改善1例,変化なし3例で,残る12例は切断となった.細胞治療時のデブリードメントや治療後の二次閉塞の予防が重要である.
Theme Dialysis in Diabetic Patients
Title Therapeutic angiogenesis for diabetic patients using peripheral blood stem cell collection (PBSCC)
Author Takashi Horie Department of Surgery, Sapporo Hokuyu Hospital
Author Akio Kawamura Department of Surgery, Sapporo Hokuyu Hospital
Author Ichiro Tsuda Department of Surgery, Sapporo Hokuyu Hospital
[ Summary ] Therapeutic angiogenesis, using bone marrow cell transplantation, has been reported on. This therapy was useful for arterio sclerosis obliterans (ASO). We attempted the same procedure using PBSCC. Sixty-five patients were included in this study, 16 were diabetic hemodialysis patients with gangrene of the limbs. The patients were given 5µg / kg / day G-CSF for 4 days subcutaneously. PBSCC was done on day 4. For each patient, 8 to 10l of peripheral blood was treated with an apheresis machine (CS-3000 or Spectra) and 0.2 to 15.9 × 107 CD34 cells were harvested with mononuclear cells, red blood cells and platelets. We did not purify the CD34 cells using the magnetic beads method. CD34 enriched fluid (35 to 93ml) was injected at 60 to 190 points into limb muscle on the same day. Forty of 65 patients recovered. However, 12 out of 16 gangrenous patients received amputations because their necrotic ulcers were painful and infected.
戻る